CN105732796A - Cobra venom nerve growth factor purification and preparation method - Google Patents

Cobra venom nerve growth factor purification and preparation method Download PDF

Info

Publication number
CN105732796A
CN105732796A CN201610268411.8A CN201610268411A CN105732796A CN 105732796 A CN105732796 A CN 105732796A CN 201610268411 A CN201610268411 A CN 201610268411A CN 105732796 A CN105732796 A CN 105732796A
Authority
CN
China
Prior art keywords
buffer
peak
activity
naja
ngf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610268411.8A
Other languages
Chinese (zh)
Inventor
张学荣
侯瑞雪
张可星
罗小玲
廖明
班建东
孙林
蔡凤桃
陈缨
农君
李洪涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi Medical University
Original Assignee
Guangxi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi Medical University filed Critical Guangxi Medical University
Priority to CN201610268411.8A priority Critical patent/CN105732796A/en
Publication of CN105732796A publication Critical patent/CN105732796A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention discloses a cobra venom nerve growth factor purification and preparation method. Firstly, a DEAE CL-6B anion exchange column is adopted and then a Sephadex G-50 gel chromatography column, a Macro-prep High S cation exchange column is utilized for separation in sequence, a PC12 cell test method is adopted to dilute collected peaks with ultra-pure water after each time of separation, and then testing is performed to select the peaks having the highest cobra venom nerve growth factor activity as samples for subsequent separation, wherein the minimum concentration of NGF induced PC12 cell differentiation is determined through dilution. An inventor finds peaks having the highest NGF activity in the cobra venom separation process and determines that the minimum concentration of the NGF induced PC12 cell differentiation is up to 0.1 micrograms/ml. Tests show that electrophoresed pure NGF can be obtained by applying the method and have high purity and high activity.

Description

Recombinant Naja naja atra NGF method for preparing purified
Technical field
The invention belongs to snake venom nerve growth factor preparation field, particularly relate to a kind of Recombinant Naja naja atra NGF purification system Preparation Method.
Background technology
Nerve growth factor (Nerve growth factor, NGF) is the nutritional labeling that nervous system is important, is ensureing god Play an important role in the normal function of system, it addition, NGF also with endocrine, immunity, reproductive system, old age Dementias etc. have close association.Its Main Function has four aspects:<1>promotes nervous system to grow during body development Grow;<2>protective effect nutritious to Normal neuronal cells after body maturation;<3>nerve injury (such as cerebrovas-cularaccident and Cerebral trauma) after can promote neuron regeneration and functional rehabilitation;<4>learning and memory function is improved.
Recombinant Naja naja atra NGF is as the main active of medicine, its good effect, rapid-action, safe and effective, malicious Side effect is little, is prevention and the ideal medicament for the treatment of nervous system disease.Existing cobra venom NGF is isolated and purified mainly to be adopted With the combination of gel filtration chromatography method Yu ion exchange chromatography, and after isolated and purified, use PC12 cell method, two-way immunity Institute's separating resulting is verified by the methods such as diffusion method or SDS-PAGE electrophoresis method, but owing to the influence factor of post effect is various, And be difficult to be controlled by, therefore the poor repeatability of this type of method, the activity of the NGF obtained is relatively low.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of simple, efficient, controlled Recombinant Naja naja atra NGF purification Preparation method.
For solve above-mentioned technical problem, the present invention by the following technical solutions:
Recombinant Naja naja atra NGF method for preparing purified, first uses DEAE CL-6B anion-exchange column then to recycle Sephadex G-50 gel chromatography column, Macro-prep High S cation exchange column separate successively, separate every time After choose the sample that separates as lower step of the highest peak of snake venom nerve growth factor activity.
Choose the highest peak of snake venom nerve growth factor activity and use PC12 cellular assay method, with ultra-pure water to collected each Test after peak dilution.
Extension rate is 10 times, 100 times, 1000 times, 10000 times.
Above-mentioned Recombinant Naja naja atra NGF method for preparing purified, comprises the following steps:
(1) DEAE CL-6B anion-exchange column eluting separates;
(2) Sephadex G-50 gel chromatography column eluting separates;
(3) Macro-prep High S cation exchange column eluting separates.
Step (1) is carried out by following operation: DEAE CL-6B post buffer A is balanced 8h, then the sample that will prepare It is splined on the pillar balanced, uses buffer B to carry out eluting by the elution program arranged, collect each peak respectively, use PC12 Each peak snake venom nerve growth factor activity is measured by cellular assay method, chooses the peak lyophilizing that activity is the highest, standby;Buffering Liquid A is the Tris-HCl buffer of 0.05M, pH8.5;Buffer B is the NaCl solution of 0.5M, pH8.5.
The preparation of sample is carried out by following operation: weigh cobra venom lyophilized powder 1g, adds 10ml level pad, and 4 DEG C molten Solve 4h;To be dissolved completely after, 8000rpm, 4 DEG C of centrifugal 15min;Take supernatant, first cross 0.45 μm filter membrane, after 0.22 μm After filter membrane, standby;Level pad is the Tris-HCl buffer of 0.05M, pH8.5.
Step (2) is carried out by following operation: by the lyophilized powder of activity summit in step (1), add 5ml PB buffer After fully dissolving, it is splined on the G-50 gel column that PB buffer balances, uses PB buffer by the elution program arranged Carry out eluting, collect each peak respectively, use PC12 cellular assay method that each peak snake venom nerve growth factor activity is measured, Choose the peak lyophilizing that activity is the highest, standby;PB buffer be the sodium dihydrogen phosphate of 0.02M and the disodium hydrogen phosphate of 0.02M by The buffer of ratio 137: 63 mixed preparing, after mixing, pH of buffer is 6.5.
Step (3) is carried out by following operation: by the lyophilized powder of activity summit in step (2), add 1ml PB buffer After fully dissolving, 10000rpm is centrifuged 15min, takes supernatant, after crossing 0.22 μm filter membrane, is splined on PB buffer and puts down The Macro-prep High S post weighed, uses buffer B to carry out eluting by the elution program arranged, collects each peak respectively, Use PC12 cellular assay method that each peak snake venom nerve growth factor activity is measured, choose the peak lyophilizing that activity is the highest, Preserve in-20 DEG C of refrigerators;The PB buffer dissolved is 0.02M, pH4.0;The PB buffer of balance is 0.02M, pH6.5;Buffer B is the NaCl solution of 0.5M, pH6.5.(note: the PB buffer dissolved is by balance use PB buffer adds a small amount of acetic acid, regulates pH to 4.0;Balance the sodium dihydrogen phosphate that PB buffer is 0.02M and The buffer of the disodium hydrogen phosphate of 0.02M 137: 63 mixed preparing in proportion, after mixing, pH of buffer is 6.5.)
PC12 cellular assay method is carried out by following operation: with ultra-pure water, collected each peak is diluted 10 times respectively, 100 times, 1000 times, after 10000 times, add 48 orifice plates containing PC12 cell, observation of cell state after 72h.
The problem existed for the preparation of current Recombinant Naja naja atra NGF, it is raw that inventor establishes a kind of cobra neurotoxin Long factor method for preparing purified, first uses DEAE CL-6B anion-exchange column then to recycle Sephadex G-50 gel Chromatographic column, Macro-prep High S cation exchange column separate successively, use PC 12 cellular assay after separating every time Method ultra-pure water choose testing after the dilution of collected each peak the highest peak of snake venom nerve growth factor activity as under The sample that step separates.Wherein, by the Cmin of dilution metering NGF PC 12 cells Induced by differentiation, inventor have found The most highly active peak of NGF in snake venom separation process, and determine that the Cmin of NGF PC 12 cells Induced by differentiation reaches 0.1 μg/ml.Test shows, the application present invention can get electrophoretically pure NGF, and its purity is high, activity is high.
Accompanying drawing explanation
Fig. 1 is G-50 post separating resulting.
Fig. 2 is CM CL-6B anion column separating resulting.
Fig. 3 is DEAE CL-6B anion column separating resulting.
Fig. 4 is G-50 gel column separating resulting.
Fig. 5 is High S cation seperation column separating resulting.
Fig. 6 is PC12 cellular identification result (light microscopic 10 ×).
Fig. 7 is cell state (light microscopic 20 ×) after NGF effect 72h.
Fig. 8 is the isolated and purified result of SDS-PAGE electroresis appraisal.
Detailed description of the invention
1 materials and methods
(Guangxi Medical University's snake venom institute provides, and Naja is Reptilia for 1.1 instruments and reagent Guangxi Cobra Venom lyophilized powder Squamata Ophidia Elapidae Elaps, naja atra Cantor, Latin entitled naja atra), electronic analytical balance (English Sartorius company of state), L18-4584-01 system (Pharmacia Biotech company of the U.S.), BioLogic DuoFlow System (BIO-RAD company of the U.S.), CO2Incubator (Thermo Forma company of the U.S.), the 1640 culture medium (U.S. Gbico company), hyclone (Wisnt company of Canada), horse serum (Hyclone company of the U.S.), other examinations Agent is domestic analytical pure.
1.2 experimental technique
1.2.1PC12 cell is cultivated the PC12 cell 1640 culture medium containing 10% horse serum and 5% hyclone, in 5%CO2, the incubator of 37 DEG C is cultivated.Take the good PC12 cell of growth conditions and be inoculated in 48 orifice plates, stand-by.
1.2.2 sample preparation weighs cobra venom lyophilized powder 1g, adds 10ml buffer (putting down of the chromatographic column that will use Weighing apparatus buffer), 4 DEG C dissolve 4h.To be dissolved completely after, 8000rpm, 4 DEG C of centrifugal 15min.Take supernatant, first cross 0.45 μm Filter membrane, after 0.22 μm filter membrane, standby.(note: original method first step is G-50 gel column, buffering used Liquid is 1%HAc;The improved method first step is DEAE CL-6B ion exchange column, and buffer used is the (Tris-HCl of 0.05M Buffer, pH8.5.)
((1st) step specimen in use is the 10ml sample in 1.2.2 to the most original method, (2nd) step specimen in use It is the Peak Activity sample that obtains of (1st) step)
(1) after G-50 gel column is balanced 8h with the HAc buffer of 1% by G-50 gel column, then the sample that will have configured Being splined on pillar, arrange elution program as shown in table 1, eluent used is 1%HAc.Collect each peak respectively, and join Containing 48 orifice plates of PC12 cell, observation of cell state after 72h, by Peak Activity lyophilizing, standby.
(2) the NaAc-HAc buffer (pH5.8) of CM CL-6B post 0.025M is put down by CM CL-B6 cation seperation column After weighing apparatus 8h, then the Peak Activity of G-50 being splined on pillar, arrange elution program as shown in table 2, wherein buffer B is 1M NaCl solution, pH5.8.Collect each peak respectively, and join 48 orifice plates containing PC12 cell, observe after 72h Cell state, by Peak Activity lyophilizing, standby.
1.2.4 ((1st) step specimen in use is the 10ml sample in 1.2.2 to improved method, (2nd) step specimen in use Being the most highly active peak sample that obtains of (1st) step, (3rd) step specimen in use is the most highly active peak arrived of (2nd) step Sample)
(1) DEAE CL-6B anion column by DEAE CL-6B post with buffer A (the Tris-HCl buffer of 0.05M, PH8.5) balance 8h, then the sample prepared is splined on the pillar balanced, it is as shown in table 3 that elution program is set, wherein Buffer B is the NaCl solution of 0.5M, pH8.5.Collect each peak respectively, and dilute 10 times with ultra-pure water respectively, 100 Times, 1000 times, after 10000 times, add 48 orifice plates containing PC12 cell, observation of cell state after 72h.By NGF The peak lyophilizing that activity is the highest, standby.
(2) G-50 gel column is by the lyophilized powder of NGF activity summit in DEAE CL-6B, add 5ml PB buffer (0.02M, PH6.5), after fully dissolving, it is splined on the G-50 gel column that PB buffer balances.Elution program is as shown in table 4.Point Do not collect each peak, and dilute 10 times with ultra-pure water respectively, 100 times, 1000 times, add containing PC12 thin after 10000 times 48 orifice plates of born of the same parents, observation of cell state after 72h.By peak lyophilizing the highest for NGF activity, standby.
(3) Macro-prep High S cation seperation column takes NGF activity summit lyophilized powder in G-50, adds 1ml PB and delays Rush liquid (0.02M, pH4.0) fully to dissolve.To be dissolved completely after, 10000rpm, centrifugal 15min.Take supernatant, mistake After 0.22 μm filter membrane, it is splined on the Macro-prep High S post that PB buffer (0.02M, pH6.5) has balanced.Wash De-program is as shown in table 5.Wherein buffer B is the NaCl solution of 0.5M, pH6.5.Collect each peak respectively, and with super Pure water dilutes 10 times respectively, 100 times, 1000 times, adds 48 orifice plates containing PC12 cell, in 72h after 10000 times Rear observation of cell state.By peak lyophilizing the highest for NGF activity, in-20 DEG C of preservations.
1.2.5SDS-PAGE electrophoresis takes High S post isolated Peak Activity lyophilized powder aqueous solution (concentration is 4mg/ml) 16 μ l, add 4 μ l albumen sample-loading buffer (producers: the green skies;Article No.: P0015L), mixing is placed on boiling water bath Middle 3min, is splined on the SDS-PAGE glue of 12%.Wherein concentrating glue part applied voltage is 60V, the electricity consumption of separation gel part institute Pressure is 120V, when the blue bands of albumen sample-loading buffer runs to time at 1cm at the bottom of separation gel, stops electrophoresis.Coomassie is bright Blue R-250 dyeing 4h rear decoloring.
1.2.6SDS-PAGE non denatured electrophoresis takes mgh S post isolated Peak Activity lyophilized powder aqueous solution (concentration is 4mg/ml) 16 μ l, adds 4 μ l non-denatured protein sample-loading buffer (producers: the green skies;Article No.: P0016N), mixed Directly on PAGE gel, non denatured electrophoresis is carried out, without β-mercapto in non-denatured protein sample-loading buffer therein after even Base ethanol etc. can make the composition that protein disulfide bond destroys.Voltage and the same 1.2.4 of dyeing time.
1.2.7 the minimum NGF concentration of PC 12 cells Induced by differentiation is by the isolated and purified pure NGF of the electrophoresis obtained, the dilutest Releasing to protein concentration is 0.1 μ g/ml, after 0.5 μ g/ml, 1 μ g/ml, 2 μ g/ml and 4 μ g/ml, adds containing PC12 24 orifice plates of cell, each concentration arranges 3 multiple holes, observation of cell state after 72 hours.
2 results
2.1 former methodical separating resulting G-50 post separating resultings are as it is shown in figure 1, arrow indication is to reflect through PC12 cell Fixed Peak Activity.CM CL-6B post separating resulting is as in figure 2 it is shown, arrow indication is the Peak Activity through PC12 cellular identification.
The separating resulting DEAE CL-6B anion column separating resulting of 2.2 improved methods is as it is shown on figure 3, arrow indication is warp The active summit (45-55 pipe) of PC12 cellular identification.G-50 gel column separating resulting as shown in Figure 4, arrow institute Refer to as the active summit (6-21 pipe) through PC12 cellular identification.High S cation seperation column separating resulting as it is shown in figure 5, Arrow indication is the active summit (26-30 pipe) through PC12 cellular identification.It is computed, 2g cobra venom lyophilized powder Isolated and purified yield is 0.24%.
The 2.3 PC12 cells passing through PC12 cellular identification most highly active peak result regular culture conditions (blank group) are circle Shape, ellipse or some irregular shapes, there is no obvious projection, such as A in Fig. 6;In the presence of having NGF, after 72h, can See that almost each cell all grows raised from cell space to surrounding, can form network-like structure, such as B in Fig. 6;And deposit without NGF Time, substantially without significant change, such as C in Fig. 6.
As shown in table 6 by the NGF activity result of each detached peaks of PC12 cell detection difference extension rate, wherein "-" generation Table without NGF activity, "+" represent have NGF activity.
The minimum NGF concentration of 2.4 PC 12 cells Induced by differentiations is by Macro-prep High S post the highest isolated work Property peak press pipe collect, often pipe is diluted to protein concentration respectively is 0.1 μ g/ml, 0.5 μ g/ml, 1 μ g/ml, 2 μ g/ml After 4 μ g/ml, adding 48 orifice plates containing PC12 cell, each concentration of each sample arranges 3 multiple holes, in 72 Observation of cell state after hour, and record each activity.
After the NGF activity peak effect PC12 cell 72h of variable concentrations, cell substantially has three shown in Fig. 7 kind state. The relative activity of Macro-prep High S post isolated most highly active peak different parts is as shown in table 7, and draw can The Cmin making PC12 cell break up is 0.1 μ g/ml.
2.5SDS-PGAE electrophoresis result through SDS-PAGE electroresis appraisal, Macro-prep High S post gained through PC12 It is pure that the NGF activity peak of cellular identification has reached electrophoresis.Wherein the band of Denatured protein is below 15kDa, sees A in Fig. 8.Non- Denaturing protein electrophoresis result is also single band, and as shown in B in Fig. 8, band is below 25kDa.Known albumen mobility The logarithm of X and molecular weight Mr is linear, meets logMr=aX+b, and wherein a, b are constant.With X as abscissa, LogMr is that vertical coordinate draws standard curve, and the formula obtaining Fig. 8 A is logMr=-1.3768X+5.186, R2=0.963, through meter Calculating, the molecular weight of degeneration NGF is about 14kDa.The formula of Fig. 8 B is logMr=-1.2684X+5.1201, R2=0.951, Being computed, the molecular weight of non denatured NGF is about 23.3kDa.
The contrast of 2.6 original methods and improved method by buffer used, the isolated and purified time, Peak Activity number and The Cmin that final separation result can make PC12 break up makes contrast, and comparing result is shown in Table 8.Can obtain from table, improvement side Method required time is shorter, and the Peak Activity of gained is simple spike, and the NGF activity obtained is relatively in the past higher.
Table 1G-50 elution program
Table 2CM CL-6B elution program
DEAE CL-6B elution program in table 3 present invention
G-50 elution program in table 4 present invention
Macro-prep High S elution program in table 5 present invention
NGF activity after the dilution of table 6 improved method each detached peaks
Table 7Macro-prep High S most highly active peak
The original method of table 8 and the contrast of improved method

Claims (9)

1. a Recombinant Naja naja atra NGF method for preparing purified, it is characterised in that: first use DEAE CL-6B anion to hand over Change that then post recycles Sephadex G-50 gel chromatography column, Macro-prep High S cation exchange column enters successively Row separates, and chooses the sample that the highest peak of snake venom nerve growth factor activity separates as lower step after separating every time.
Recombinant Naja naja atra NGF method for preparing purified the most according to claim 1, it is characterised in that described in choose Serpentis The peak that poison Nerve Growth Factor Activity is the highest uses PC12 cellular assay method, after diluting collected each peak with ultra-pure water Test.
Recombinant Naja naja atra NGF method for preparing purified the most according to claim 3, it is characterised in that described dilution times Number is 10 times, 100 times, 1000 times, 10000 times.
Recombinant Naja naja atra NGF method for preparing purified the most according to claim 1, it is characterised in that include following step Rapid:
(1) DEAE CL-6B anion-exchange column eluting separates;
(2) Sephadex G-50 gel chromatography column eluting separates;
(3) Macro-prep High S cation exchange column eluting separates.
Recombinant Naja naja atra NGF method for preparing purified the most according to claim 1, it is characterised in that step (1) is pressed Hereinafter operation is carried out: DEAE CL-6B post buffer A balances 8h, then is splined on by the sample prepared and balances Pillar, use buffer B to carry out eluting by the elution program arranged, collect each peak respectively, use the inspection of PC12 cell Each peak snake venom nerve growth factor activity is measured by method of testing, and chooses the peak lyophilizing that activity is the highest, standby;Described slow Rush the Tris-HCl buffer that liquid A is 0.05M, pH8.5;Described buffer B is the NaCl solution of 0.5M, pH8.5.
Recombinant Naja naja atra NGF method for preparing purified the most according to claim 1, it is characterised in that described sample Preparation is carried out by following operation: weigh cobra venom lyophilized powder 1g, adds 10ml level pad, and 4 DEG C dissolve 4h; To be dissolved completely after, 8000rpm, 4 DEG C of centrifugal 15min;Take supernatant, first cross 0.45 μm filter membrane, after 0.22 μm After filter membrane, standby;Described level pad is the Tris-HCl buffer of 0.05M, pH8.5.
Recombinant Naja naja atra NGF method for preparing purified the most according to claim 1, it is characterised in that step (2) is pressed Hereinafter operation is carried out: by the lyophilized powder of activity summit in step (1), adds after 5ml PB buffer fully dissolves, It is splined on the G-50 gel column that PB buffer balances, uses PB buffer to carry out eluting by the elution program arranged, Collect each peak respectively, use PC12 cellular assay method that each peak snake venom nerve growth factor activity is measured, choose work The peak lyophilizing that property is the highest, standby;Described PB buffer is sodium dihydrogen phosphate and the disodium hydrogen phosphate of 0.02M of 0.02M The buffer of 137: 63 mixed preparing in proportion, after mixing, pH of buffer is 6.5.
Recombinant Naja naja atra NGF method for preparing purified the most according to claim 1, it is characterised in that step (3) is pressed Hereinafter operation is carried out: by the lyophilized powder of activity summit in step (2), adds after 1ml PB buffer fully dissolves, 10000rpm is centrifuged 15min, takes supernatant, after crossing 0.22 μm filter membrane, is splined on what PB buffer balanced Macro-prep High S post, uses buffer B to carry out eluting by the elution program arranged, collects each peak respectively, adopt By PC12 cellular assay method, each peak snake venom nerve growth factor activity is measured, chooses the peak lyophilizing that activity is the highest, Preserve in-20 DEG C of refrigerators;The PB buffer of described dissolving is 0.02M, pH4.0;The PB buffering of described balance Liquid is 0.02M, pH6.5;Described buffer B is the NaCl solution of 0.5M, pH6.5.
9. according to the Recombinant Naja naja atra NGF method for preparing purified described according to claim 5 to 7, it is characterised in that PC12 Cellular assay method is carried out by following operation: with ultra-pure water, collected each peak is diluted 10 times respectively, 100 times, and 1000 Times, add 48 orifice plates containing PC12 cell, observation of cell state after 72h after 10000 times.
CN201610268411.8A 2016-04-27 2016-04-27 Cobra venom nerve growth factor purification and preparation method Pending CN105732796A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610268411.8A CN105732796A (en) 2016-04-27 2016-04-27 Cobra venom nerve growth factor purification and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610268411.8A CN105732796A (en) 2016-04-27 2016-04-27 Cobra venom nerve growth factor purification and preparation method

Publications (1)

Publication Number Publication Date
CN105732796A true CN105732796A (en) 2016-07-06

Family

ID=56285660

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610268411.8A Pending CN105732796A (en) 2016-04-27 2016-04-27 Cobra venom nerve growth factor purification and preparation method

Country Status (1)

Country Link
CN (1) CN105732796A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107098956A (en) * 2017-03-13 2017-08-29 广西医科大学 Cytotoxin 4N method for preparing purified and its application
CN113214379A (en) * 2021-04-07 2021-08-06 云南龙凤谷生物药业有限公司 Preparation method of cobra venom nerve growth factor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1255503A (en) * 1999-11-09 2000-06-07 边六交 Method for purifying nerve growth factor from snake venom

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1255503A (en) * 1999-11-09 2000-06-07 边六交 Method for purifying nerve growth factor from snake venom

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
候瑞雪等: "广西眼镜蛇毒神经生长因子分离纯化方法", 《基因组学与应用生物学》 *
吴鹏: "从中华眼镜蛇蛇毒中分离纯化神经生长因子的色谱工艺研究", 《中国优秀硕士学位论文全文数据库工程科技I辑》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107098956A (en) * 2017-03-13 2017-08-29 广西医科大学 Cytotoxin 4N method for preparing purified and its application
CN107098956B (en) * 2017-03-13 2021-02-09 广西医科大学 Purification preparation method and application of cobra venom cytotoxin-4N
CN113214379A (en) * 2021-04-07 2021-08-06 云南龙凤谷生物药业有限公司 Preparation method of cobra venom nerve growth factor

Similar Documents

Publication Publication Date Title
Manthorpe et al. Cholinergic neuronotrophic factors: fractionation properties of an extract from selected chick embryonic eye tissues
Deibler et al. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
Himmelhoch et al. Purification of myeloperoxidases from bone marrow
Mosevitsky et al. Tissue specificity of nucleo‐cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions
Kitamura et al. Purification and partial characterization of two glycoproteins in bovine peripheral nerve myelin membrane
Eng et al. Antibody to bovine choline acetyltransferase and immunofluorescent localisation of the enzyme in neurones
Björkman et al. Studies on myrosinases: I. Purification and characterization of a myrosinase from white mustard seed (Sinapis alba, L.)
Kandutsch et al. PARTIAL PURIFICATION OF TISSUE ISOANTIGENS FROM A MOUSE SARCOMA1, 2
Curling et al. A chromatographic procedure for the purification of human plasma albumin
CN108524929B (en) A kind of production method of rabies vacciness
Sidhu et al. Purification and polypeptide characterization of complex III from yeast mitochondria.
DE2258822A1 (en) METHODS AND MEANS OF ANALYSIS OF ISOENZYME PATTERNS
CN108623677A (en) A kind of method of purification of intravenous human immunoglobulin(HIg)
Shashoua Brain metabolism and the acquisition of new behaviors. III. Evidence for secretion of two proteins into the brain extracellular fluid after training
CN105732796A (en) Cobra venom nerve growth factor purification and preparation method
Lim et al. Studies on brain-specific membrane proteins
Stern et al. Serum proteins in mongolism
CN108611343B (en) Method for separating and purifying natural protease 3 from azurophilic granules of human blood neutrophils
Marr et al. Studies on the growth-promoting glycoprotein fraction of foetal calf serum
CN106497903B (en) A kind of technique for purifying blood coagulation proenzyme compound
Chayen Pectinase technique for isolating plant cells
Feher et al. Evidence for a membrane-bound fraction of chick intestinal calcium-binding protein
CN111530439A (en) Method for preparing specific antibody of definite value syphilis in serum
Watson et al. The cilia of Tetrahymena pyriformis: Fractionation of isolated cilia
CN106279397A (en) A kind of extracting method of nerve growth factor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160706

RJ01 Rejection of invention patent application after publication